-
Mashup Score: 1STAT Reports - 29 day(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2STAT Reports - 1 month(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0STAT Reports - 2 month(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Clinical trial subgroup analysis: How to evaluate post hoc tests for significance in failed clinical trials - 4 month(s) ago
In this report, author Frank David, M.D., Ph.D., explores the three key reasons to be skeptical when interpreting findings from post hoc subgroup analyses, drawing from real-world examples of biotech companies that succeeded or failed. This guide emphasizes a data-centric evaluation valuable to investors, researchers, patients, and others.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 72023 Update: STAT’s guide to interpreting clinical trial results - 5 month(s) ago
There is an art to reading, and writing, scientific results – and you can learn it. STAT’s bestselling report is now updated to provide the tools to help you read clinical trial results with an appropriately skeptical (or critical) eye. This report gives you the foundation you need to make smarter business decisions.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22023 Update: STAT’s guide to interpreting clinical trial results - 5 month(s) ago
There is an art to reading, and writing, scientific results – and you can learn it. STAT’s bestselling report is now updated to provide the tools to help you read clinical trial results with an appropriately skeptical (or critical) eye. This report gives you the foundation you need to make smarter business decisions.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
In this STAT Report author Frank David, M.D., Ph.D., explores the question, how can you tell if there’s still hope a drug will be approved when a pivotal trial fails? The answer offers investors and biotech companies context and insights that can help in evaluating a path to market for failed drugs with real examples. Read more in Failed trial, successful drug: How a negative readout can lead to FDA approval.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Clinical trial delays: what they mean and why you should care - 6 month(s) ago
When it comes to clinical trials, time is money. And a delay in a trial can mean a drop in a drug’s net value, lost ground to competitors, or an increased risk of failure — or it can signal more bad news to come.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
In this report, author Frank David, M.D., Ph.D., explores the three key reasons to be skeptical when interpreting findings from post hoc subgroup analyses, drawing from real-world examples of biotech companies that succeeded or failed. This guide emphasizes a data-centric evaluation valuable to investors, researchers, patients, and others.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7
In this report, author Frank David, M.D., Ph.D., explores the three key reasons to be skeptical when interpreting findings from post hoc subgroup analyses, drawing from real-world examples of biotech companies that succeeded or failed. This guide emphasizes a data-centric evaluation valuable to investors, researchers, patients, and others.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
Act now and get all three of @Frank_S_David's clinical trial reports for a fraction of the cost when you use the code BUNDLE. Offer ends today: https://t.co/cEMsccJQLv #STATReports https://t.co/Y1IZ81qTfn